deferasirox msn 360mg potahovaná tableta
msn labs europe limited, paola array - 16626 deferasirox - potahovaná tableta - 360mg - deferasirox
deferasirox msn 90mg potahovaná tableta
msn labs europe limited, paola array - 16626 deferasirox - potahovaná tableta - 90mg - deferasirox
femoston 1mg+1mg/10mg potahovaná tableta
theramex ireland limited, dublin array - 13226 hemihydrÁt estradiolu; 13226 hemihydrÁt estradiolu; 6073 dydrogesteron - potahovaná tableta - 1mg+1mg/10mg - dydrogesteron a estrogen
femoston 2mg+2mg/10mg potahovaná tableta
theramex ireland limited, dublin array - 13226 hemihydrÁt estradiolu; 13226 hemihydrÁt estradiolu; 6073 dydrogesteron - potahovaná tableta - 2mg+2mg/10mg - dydrogesteron a estrogen
femoston conti 1mg/5mg potahovaná tableta
theramex ireland limited, dublin array - 13226 hemihydrÁt estradiolu; 6073 dydrogesteron - potahovaná tableta - 1mg/5mg - dydrogesteron a estrogen
femoston mini 0,5mg/2,5mg potahovaná tableta
theramex ireland limited, dublin array - 13226 hemihydrÁt estradiolu; 6073 dydrogesteron - potahovaná tableta - 0,5mg/2,5mg - dydrogesteron a estrogen
imigran 6mg injekční roztok v zásobní vložce
glaxosmithkline (ireland) limited, dublin array - 10645 sumatriptan-sukcinÁt - injekční roztok v zásobní vložce - 6mg - sumatriptan
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastická činidla - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
cynt 0,2mg potahovaná tableta
viatris healthcare limited, dublin array - 9054 moxonidin - potahovaná tableta - 0,2mg - moxonidin
cynt 0,3mg potahovaná tableta
viatris healthcare limited, dublin array - 9054 moxonidin - potahovaná tableta - 0,3mg - moxonidin